Related Experiment Video
Updated: May 23, 2025

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Jiaao Sun1, Shiyan Song1, Jiahua Liu1
1Department of Urology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
Abstract:
In order to decipher the relationship between gut microbiota imbalance and cancer, this paper reviewed the role of intestinal microbiota in anticancer therapy and related mechanisms, discussed the current research status of gut microbiota as a biomarker of cancer, and finally summarized the reasonable means of regulating gut microbiota to assist cancer therapy. Overall, our study reveals that the gut microbiota can serve as a potential target for improving cancer management.
Insights
Gut microbiota imbalance is linked to cancer. Modulating gut bacteria shows potential for improving cancer therapy and management strategies.
Area of Science:
- Oncology
- Microbiology
- Immunology
Background:
- The gut microbiota plays a crucial role in host health and disease.
- Imbalances in gut microbial composition (dysbiosis) are increasingly associated with various cancers.
- Understanding this relationship is vital for developing novel therapeutic approaches.
Purpose of the Study:
- To review the role of intestinal microbiota in anticancer therapy.
- To discuss gut microbiota as a potential biomarker for cancer detection and prognosis.
- To summarize methods for regulating gut microbiota to aid cancer treatment.
Main Methods:
- Literature review of existing research on gut microbiota and cancer.
- Analysis of mechanisms linking gut microbiota to cancer development and treatment response.
- Synthesis of current findings on microbiota-based cancer biomarkers.
- Evaluation of strategies for microbiota modulation in cancer therapy.
Main Results:
- Gut microbiota influences the efficacy of various anticancer therapies.
- Specific microbial signatures may serve as biomarkers for certain cancers.
- Dysbiosis is a common feature in cancer patients.
- Targeted interventions can modulate the gut microbiota composition.
Conclusions:
- The gut microbiota represents a promising therapeutic target for cancer management.
- Further research is needed to fully elucidate the complex interactions between gut microbes and cancer.
- Personalized microbiota-based strategies could enhance cancer treatment outcomes.
More Related Videos
06:07Evaluating Cell Death Using Cell-Free Supernatant of Probiotics in Three-Dimensional Spheroid Cultures of Colorectal Cancer Cells
Published on: June 13, 2020
08:14A Method to Define the Effects of Environmental Enrichment on Colon Microbiome Biodiversity in a Mouse Colon Tumor Model
Published on: February 28, 2018
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Tumor Microenvironment
Mitogens and the Cell Cycle
Drugs that Stabilize Microtubules
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...